Ascendis Pharma A (ASND) Depreciation & Amortization - Total (2013 - 2026)
Powered by 
Analysis
Ascendis Pharma A (ASND) Depreciation & Amortization - Total (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 16.36 Bn | 15.42 Bn | 362.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | 7.12 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 5.26 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 17.87 Mn |
| Dec 31, 2021 | 17.10 Mn |
| Dec 31, 2017 | -864,235.47 |
| Dec 31, 2016 | -730,973.30 |
| Dec 31, 2015 | -611,633.44 |
| Dec 31, 2014 | -629,916.08 |
| Dec 31, 2013 | -551,241.27 |